Evangelos Terpos Selected Research

Monoclonal Antibodies

9/2023	Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era.
4/2023	Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis.
9/2021	BCMA in Multiple Myeloma-A Promising Key to Therapy.
9/2021	Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.
1/2021	The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.
1/2021	Real-World Treatment of Patients With Relapsed/Refractory Myeloma.
1/2020	Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient Selection.
1/2019	Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: can they change the standard of care?
1/2019	Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma.
11/2018	Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Evangelos Terpos Research Topics

Disease

207	Multiple Myeloma 04/2024 - 01/2003
68	Neoplasms (Cancer) 03/2024 - 10/2004
51	Bone Diseases (Bone Disease) 02/2024 - 09/2003
39	COVID-19 02/2024 - 01/2020
30	Bone Resorption 08/2021 - 01/2003
27	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2024 - 06/2007
19	Infections 11/2023 - 05/2008
18	Immunoglobulin Light-chain Amyloidosis 11/2023 - 10/2007
15	Osteoporosis 07/2021 - 11/2003
15	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2007
14	Monoclonal Gammopathy of Undetermined Significance 02/2024 - 09/2004
12	Disease Progression 02/2024 - 09/2003
12	Pain (Aches) 09/2023 - 01/2004
12	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 06/2008
12	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 12/2008
11	Anemia 01/2024 - 05/2008
10	Thalassemia 01/2024 - 07/2005
9	Thrombocytopenia (Thrombopenia) 11/2023 - 01/2002
9	beta-Thalassemia (Cooley's Anemia) 12/2019 - 06/2006
8	Thrombosis (Thrombus) 02/2024 - 09/2013
8	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2008
8	Osteonecrosis (Kienbock's Disease) 05/2019 - 07/2006
7	Non-alcoholic Fatty Liver Disease 05/2024 - 01/2013
7	Inflammation (Inflammations) 04/2024 - 02/2011
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 02/2009
7	Neutropenia 10/2023 - 08/2007
7	Prostatic Neoplasms (Prostate Cancer) 09/2022 - 01/2007
7	Iron Overload 01/2022 - 07/2005
7	Residual Neoplasm 12/2021 - 01/2017
7	Spontaneous Fractures (Pathological Fracture) 01/2021 - 01/2003
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2015 - 01/2002
6	Cardiotoxicity 04/2024 - 01/2019
6	Chromosome Aberrations (Chromosome Abnormalities) 08/2023 - 07/2012
6	Lymphoma (Lymphomas) 09/2021 - 05/2007
6	Spinal Cord Compression 01/2021 - 01/2004
6	Hypercalcemia (Milk Alkali Syndrome) 01/2020 - 01/2004
6	Renal Insufficiency (Renal Failure) 05/2016 - 05/2008
5	Ovarian Neoplasms (Ovarian Cancer) 09/2022 - 02/2008
5	Plasmacytoma 01/2020 - 11/2005
5	Peripheral Nervous System Diseases (PNS Diseases) 10/2019 - 12/2009
5	Hemolysis 07/2019 - 01/2002

Drug/Important Bio-Agent (IBA)

54	Bortezomib (Velcade)FDA Link 12/2023 - 10/2004
45	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 02/2006
42	Lenalidomide (CC 5013)FDA Link 03/2024 - 07/2010
35	Diphosphonates (Bisphosphonates)IBA 06/2021 - 01/2003
30	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2003
30	Zoledronic Acid (Zometa)FDA Link 06/2021 - 07/2006
26	Proteasome InhibitorsIBA 10/2023 - 10/2004
22	OsteoprotegerinIBA 01/2019 - 08/2003
21	Neutralizing AntibodiesIBA 11/2023 - 01/2021
20	carfilzomibIBA 04/2024 - 02/2017
20	Monoclonal AntibodiesIBA 09/2023 - 08/2007
20	Denosumab FDA Link 08/2021 - 04/2009
18	AntibodiesIBA 11/2023 - 06/2016
18	Collagen Type I (Type I Collagen)IBA 01/2014 - 01/2003
17	VaccinesIBA 01/2024 - 01/2021
17	daratumumabIBA 01/2024 - 01/2018
17	BNT162 VaccineIBA 03/2023 - 01/2021
17	RANK LigandIBA 11/2018 - 08/2003
17	Alkaline PhosphataseIBA 05/2017 - 01/2003
16	Immunoglobulin M (IgM)IBA 01/2024 - 06/2007
15	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2004
15	OsteocalcinIBA 12/2019 - 01/2003
14	CytokinesIBA 01/2023 - 06/2007
14	Tartrate-Resistant Acid PhosphataseIBA 12/2019 - 01/2003
12	Pamidronate (Aredia)FDA LinkGeneric 06/2019 - 01/2003
10	Immunomodulating AgentsIBA 01/2024 - 01/2013
10	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 03/2009
9	pomalidomideIBA 10/2023 - 01/2013
9	Messenger RNA (mRNA)IBA 09/2023 - 02/2014
9	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 08/2007
9	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2008
9	Melphalan (Alkeran)FDA LinkGeneric 12/2022 - 01/2002
9	IronIBA 01/2019 - 07/2005
8	CreatinineIBA 02/2024 - 05/2008
8	mRNA VaccinesIBA 03/2023 - 01/2021
8	Rituximab (Mabthera)FDA Link 09/2021 - 08/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 07/2006
7	belantamab mafodotinIBA 02/2024 - 01/2021
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2002
7	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2003
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 08/2007
7	collagen type I trimeric cross-linked peptideIBA 01/2014 - 09/2004
7	OsteopontinIBA 11/2011 - 01/2006
6	ParaproteinsIBA 01/2024 - 01/2003
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 10/2008
6	LigandsIBA 06/2021 - 11/2003
6	Chemokine CCL3IBA 01/2018 - 10/2003
6	Angiopoietin-2IBA 10/2017 - 06/2007
6	Angiopoietin-1IBA 10/2017 - 06/2007
6	Protein Isoforms (Isoforms)IBA 11/2011 - 09/2003
5	MicroRNAs (MicroRNA)IBA 01/2023 - 02/2021
5	Immunoglobulin G (IgG)IBA 01/2023 - 03/2011
5	ACE-011IBA 01/2018 - 05/2011
5	Chelating AgentsIBA 03/2014 - 07/2005

Therapy/Procedure

123	Therapeutics 03/2024 - 01/2002
17	Drug Therapy (Chemotherapy) 02/2024 - 01/2003
14	Stem Cell Transplantation 09/2023 - 11/2005
13	Radiotherapy 09/2021 - 01/2003
6	Aftercare (After-Treatment) 01/2022 - 07/2006